CIRCULATING CYTOTOXIC T-LYMPHOCYTE PRECURSORS IN MAEDI-VISNA VIRUS-INFECTED SHEEP

被引:30
作者
BLACKLAWS, BA [1 ]
BIRD, P [1 ]
ALLEN, D [1 ]
MCCONNELL, I [1 ]
机构
[1] UNIV CAMBRIDGE,DEPT CLIN VET MED,CAMBRIDGE,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1099/0022-1317-75-7-1589
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Maedi-visna virus (MVV)-specific cytotoxic T lymphocytes (CTL) were detected, after in vitro culture with MW antigen and recombinant human interleukin-2, in the efferent lymph and peripheral blood of sheep chronically infected with MVV. Cytotoxicity was mediated by CD8(+) lymphocytes and was specific for particular strains of MVV. These precursor CTL were detected in the blood between day 23 and day 100 after infection via the skin. In one out of seven persistently infected sheep MVV-specific cytotoxicity was seen in uncultured peripheral blood cells. Again the effector population consisted of CD8(+) lymphocytes. The only other viral infections in which CTL have been detected in peripheral blood mononuclear cells prior to secondary stimulation are those caused by the simian and human immunodeficiency viruses.
引用
收藏
页码:1589 / 1596
页数:8
相关论文
共 45 条
[1]  
ANDERSON AA, 1994, IN PRESS CLIN IMMUNO
[2]   EARLY EVENTS IN IMMUNE EVASION BY THE LENTIVIRUS MAEDI-VISNA OCCURRING WITHIN INFECTED LYMPHOID-TISSUE [J].
BIRD, P ;
BLACKLAWS, B ;
REYBURN, HT ;
ALLEN, D ;
HOPKINS, J ;
SARGAN, D ;
MCCONNELL, I .
JOURNAL OF VIROLOGY, 1993, 67 (09) :5187-5197
[3]  
Blacklaws B. A., 1994, Cell-mediated immunity in ruminants., P199
[4]   IMMUNOGENICITY OF HERPES-SIMPLEX VIRUS TYPE-1 GLYCOPROTEINS EXPRESSED IN VACCINIA VIRUS RECOMBINANTS [J].
BLACKLAWS, BA ;
KRISHNA, S ;
MINSON, AC ;
NASH, AA .
VIROLOGY, 1990, 177 (02) :727-736
[5]   HUMAN CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T - REQUIREMENTS FOR INVITRO GENERATION AND SPECIFICITY [J].
BORYSIEWICZ, LK ;
MORRIS, S ;
PAGE, JD ;
SISSONS, JGP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1983, 13 (10) :804-809
[6]   QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE [J].
CARMICHAEL, A ;
JIN, X ;
SISSONS, P ;
BORYSIEWICZ, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :249-256
[7]   MULTIPLE SUBSETS OF HIV-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T IN HUMANS AND IN MICE [J].
CHENCINER, N ;
MICHEL, F ;
DADAGLIO, G ;
LANGLADEDEMOYEN, P ;
HOFFENBACH, A ;
LEROUX, A ;
GARCIAPONS, F ;
RAUTMANN, G ;
GUY, B ;
GUILLON, JM ;
MAYAUD, C ;
GIRARD, M ;
AUTRAN, B ;
KIENY, MP ;
PLATA, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (09) :1537-1544
[8]   VACCINIA VIRUS RECOMBINANT EXPRESSING HERPES-SIMPLEX VIRUS TYPE-1 GLYCOPROTEIN-D PREVENTS LATENT HERPES IN MICE [J].
CREMER, KJ ;
MACKETT, M ;
WOHLENBERG, C ;
NOTKINS, AL ;
MOSS, B .
SCIENCE, 1985, 228 (4700) :737-740
[9]   MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].
EMBRETSON, J ;
ZUPANCIC, M ;
RIBAS, JL ;
BURKE, A ;
RACZ, P ;
TENNERRACZ, K ;
HAASE, AT .
NATURE, 1993, 362 (6418) :359-362
[10]  
EVANS CW, 1993, THESIS U EDINBURGH